Other languages Aclaris Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 27/06/2024 BST			5-day change	1st Jan Change
1.11 ^USD	-0.45%		-1.77%	+5.71%

06-11	Transcript : Aclaris Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 11:20 AM
05-07	Transcript : Aclaris Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024

Aclaris Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07
Aclaris Therapeutics, Inc. Announces Board Resignations	03-19
Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27
Aclaris Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-27
Aclaris Therapeutics, Inc. Announces Termination of Employment of Gail Cawkwell as Chief Medical Officer	02-05
Sector Update: Health Care Stocks Weaker Late Afternoon	01-16
Sector Update: Health Care Stocks Softer Tuesday Afternoon	01-16
Aclaris Therapeutics Shares Rise; Strategic Review Announced, CEO Manion to Step Down	01-16
Aclaris Therapeutics Conducts Strategic Review of Business	01-16
Aclaris Therapeutics, Inc. Announces Executive Changes	01-16
Aclaris Therapeutics, Inc. Announces Chief Executive Officer Changes	01-16
Top Midday Decliners	01-10
Aclaris Therapeutics, Inc. Announces Top-line Results from 4-Week Phase 2b Trial of ATI-1777 for Mild to Severe Atopic Dermatitis	01-10
Aclaris Therapeutics to Trim Workforce by 46%; Shares Fall After Hours	12-19
Sun Pharmaceutical Signs Licensing Pact with Aclaris Therapeutics	12-06
Indian shares set to open at new record highs for third session	12-06
Aclaris Therapeutics Announces Patent License Agreement with Sun Pharma for Alopecia	12-05
US Equity Markets End Mixed as Inflation Data Looms	11-13
Top Midday Decliners	11-13
Sector Update: Health Care Stocks Higher in Afternoon Trading	11-13

No results for this search